Veisalgia Clinical Trial
Official title:
A Double-blind Placebo-controlled 4-Way Crossover Study to Evaluate the Efficacy of JMI-001 (an Over-the-counter Pain Medicine and an Antihistamine) in the Prophylaxis of Veisalgia in Healthy Volunteers
The purpose of this study is to determine the safety and efficacy of a combination product for the prevention of veisalgia. Common symptoms of veisalgia following the moderate consumption of alcohol includes headache, fatigue, and thirst. It is the investigators hypothesis that a combination of two drugs can alleviate or significantly reduce these symptoms when taken before the start of moderate alcohol consumption.
Some people who consume alcohol in moderation experience veisalgia. These symptoms include a
long list of adverse effects that include headache, fatigue and thirst. The mechanism by
which these effects occur has not been fully elucidated. Although, it has been documented
that alcohol causes the release of a large number of substances into the blood stream that
cause a number of physiologic changes.
A 4-arm study will help to determine the effect each agent contributes to decreasing the
alcohol induces physiologic changes and the effect when the two agents are delivered
concurrently.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03183297 -
Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001
|
Phase 1 |